FGF21 regulates hepatic metabolic pathways to improve steatosis and inflammation

FGF21 regulates hepatic metabolic pathways to improve steatosis and inflammation

The prevalence of non-alcoholic fatty liver disease (NAFLD) has increased dramatically worldwide and, subsequently, also the risk of developing non-alcoholic steatohepatitis (NASH), hepatic fibrosis, cirrhosis and cancer. Today, weight lo ss is the only available treatment, but administration of fib...

Full description

Bibliographic Details
Main Authors: Helle Keinicke, Gao Sun, Caroline M Junker Mentzel, Merete Fredholm, Linu Mary John, Birgitte Andersen, Kirsten Raun, Marina Kjaergaard
Format: Article
Language:English
Published: Bioscientifica 2020-08-01
Series:Endocrine Connections
Subjects:
fibroblast growth factor 21 (fgf21)
non-alcoholic fatty liver disease (nafld)
lipid metabolism
glucose metabolism
inflammation
Online Access:https://ec.bioscientifica.com/view/journals/ec/9/8/EC-20-0152.xml

Internet

https://ec.bioscientifica.com/view/journals/ec/9/8/EC-20-0152.xml

Similar Items